Suboxone manufacturers received complaints about dental damage from the film strips for years before adding label warnings about the risk of tooth decay and erosion, lawsuit claims.
Census of all Suboxone lawsuits will help the parties determine which tooth decay claims could be used as representative samples in early bellwether trials.
Manufacturers should have known about and failed to disclose risks of painful kratom withdrawal symptoms.
Recommendations suggest there is still a use for the highly-addictive painkillers among children, if they are prescribed correctly and carefully.
Suboxone tooth decay data will be produced as the parties work to exchange information needed to select a representative group of lawsuits for early bellwether trials.
Lawyers will meet with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, to finalize information needed to select the first cases for bellwether discovery and trials.
A report will be submitted next week about the status of investigations into thousands of Suboxone dental injury lawsuits filed on a bundled complaint.
Lawyers are expected to discuss how to select a representative group of claims involving Suboxone dental injuries during a meeting with the Court on October 5.
In response to a motion to dismiss filed by Indivior, plaintiffs indicate that the drug maker knew about the risk of tooth decay problems from Suboxone long before the FDA required an update to the label warning.
Lawyers will take actions during the pretrial proceedings that benefit all plaintiffs pursuing tooth decay lawsuits against Suboxone manufacturers, while being mentored by more experienced lawyers in the litigation.
